Glycotope

Contact
glycotope.com
+49 30 94892600

Pentixapharm Holding AG vormals Glycotope GmbH

Robert-Rössle-Straße 10
13125 Berlin
Germany

Phone

glycotope.com
Contact
Profile News
Contact

About Glycotope

Glycotope GmbH is a biotechnology company that uniquely develops tumor-specific monoclonal antibodies. We are dedicated to improving the lives of cancer patients by enabling treatment options that go beyond the current standard of care. Together with our partners in the pharmaceutical industry and academic research, we strive to combine our antibodies with complementary technologies to realize their full potential.

Read more about Glycotope
Facts about Glycotope
  • Focus : Manufacturer
  • Employees: 51-200
  • Industry : Biotechnology

News about Glycotope

Glycotope

16-Jul-2024 | business & finance

Pentixapharm Acquires Target Discovery Business of Glycotope

Pentixapharm AG, a clinical-stage biotech company discovering and developing novel targeted radiopharmaceuticals against a range of malignancies, has ...

Read news
Glycotope

12-Jul-2022 | business & finance

LegoChem Biosciences and Glycotope Announce Research Collaboration and License Agreement for an Antibody for use as Antibody Drug Conjugate

LegoChem Biosciences Inc. (LCB) and Glycotope GmbH (Glycotope) have signed a Research Collaboration and License Agreement to develop an antibody drug ...

Read news
Glycotope

24-Mar-2022 | business & finance

Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform

Expansion of senior team to focus on drug discovery and development

Read news
Glycotope

01-Feb-2022 | business & finance

Glycotope to spin-out its Service Business to the newly formed FyoniBio GmbH

Glycotope GmbH, a biotechnology company developing antibodies against proteins carrying tumor-specific carbohydrate structures, and CantonBio Deutschland ...

Read news
Glycotope

03-Nov-2017 | manufacturing

Celonic Acquires Glycotope’s Bio-manufacturing Facility

Celonic AG and Glycotope announced the successful completion of Celonic’s acquisition of Glycotope’s bio-manufacturing facility in Heidelberg, Germany. The ...

Read news
Glycotope

20-Sep-2011 | research and development

Glycotope Enrolls First Patients in Phase I Trial with TrasGEX, a Glycooptimized HER2 Biobetter Antibody

Glycotope GmbH announced the enrollment of the first patients in a phase I dose finding trial to evaluate safety and tolerability of TrasGEX™. TrasGEX™ is ...

Read news
Glycotope

08-Apr-2011 | manufacturing

Glycotope Biotechnology Expands GMP Production Facility to 11 kg Antibody per Year

Glycotope Biotechnology GmbH has initiated the setup of further clean room facilities as a first step in the expansion of its GMP-production capacities. By ...

Read news
Glycotope

17-Dec-2010 | business & finance

Glycotope Receives Innovation Award Berlin Brandenburg 2010

Glycotope GmbH has won the innovation award 2010 jointly presented by the German states of Berlin and Brandenburg in recognition of the company’s ...

Read news
Show more news about Glycotope

Here you will find Pentixapharm Holding AG vormals Glycotope GmbH